INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Grant or awardVerified data

Blackburn Kelly reported CRVO

EVP, Clinical Development · CervoMed Inc. · CervoMed Inc. — Stock Option (Right to Buy)

Side
A
Value
—
Shares
19.1K
Price
—
Executed
Oct 22, 2026
Disclosed
Oct 23, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 22 executedOct 23, 2026 disclosed

CRVO · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CRVO

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    DM
    De Rosch MarkEVP, RA and GA and PgM
    CRVOCervoMed Inc.
    Grant or award
    		A—
    19.1K sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    9
    WM
    Winton MatthewChief Commercial and Business
    CRVOCervoMed Inc.
    Grant or award
    		A—
    19.1K sh
    		Oct 22, 2026Oct 23, 2026
    traded Oct 22, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001437749-26-033429
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 22, 2026
    Published
    Oct 23, 2026
    Ingested by INSIDER
    Nov 5, 02:09 UTC
    Last re-read
    Nov 5, 02:09 UTC

    Extracted facts

    Filer
    Blackburn Kelly
    Role
    EVP, Clinical Development
    Transaction
    Grant or awardAs filed: “A”
    Asset
    CervoMed Inc. — Stock Option (Right to Buy)
    Ticker
    CRVO
    Shares
    19.1K
    Price per share
    $0
    Execution date (reported)
    Oct 22, 2026
    Owned after transaction
    19.1K shares
    Days from execution to publication
    1

    What this establishes

    Blackburn Kelly filed this Form 4 reporting a grant or award of CRVO on Oct 22, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP, Clinical Development
    Blackburn Kellycik:0001640575
    Issuer
    CervoMed Inc.cik:0001053691

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.